Delivery Order SPE2DB24D2109-SPE2DB25FHWEF

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,552.78 firm fixed-price contract is for the supply of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. This delivery order is issued under a larger $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,491.62 firm fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 1, 2023 and was awarded on August 31, 2023. This order is placed against Amerisourcebergen's Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.72 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,471.63 firm-fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 6, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,458.56 delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of October 29, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,586.09 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The award has an ultimate completion date of October 19, 2023 and was made on October 18, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a leading pharmaceutical distributor. The $50,962.68 firm-fixed-price delivery order is for the supply of 4,565,912,095 units of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,285.17 firm fixed-price delivery order is for the provision of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,030.82 firm fixed price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,418.81 firm fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHWEF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,957.32 firm fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/8/25, 9:46 AM